Abiopharma

🔍 Florek John Casimir (Director)

Company: McEwen Inc. (MUX)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 479 shares of Deferred Stock Units (Derivative)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,790.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each deferred stock unit represents a right to receive one share of the Issuer's common stock.
• F2: The deferred stock units are fully vested and will be delivered to the reporting person on the date of the reporting person's termination of continuous service from the Issuer's Board of Directors (the "Board"), subject to the reporting person's right to elect to defer delivery of the deferred stock units beyond the date of the reporting person's termination of continuous service from the Board.